ACP: AI Recommendations More Often Better Quality for Virtual Care Visits
By Elana Gotkine HealthDay Reporter
MONDAY, April 7, 2025 -- Artificial intelligence (AI) recommendations are more often rated as better quality than final recommendations of physicians for virtual care visits made by patients with respiratory, urinary, vaginal, eye, or dental symptoms, according to study published online April 4 in the Annals of Internal Medicine to coincide with the Internal Medicine Meeting, the annual meeting of the American College of Physicians, held from April 3 to 5 in New Orleans.
In a retrospective cohort study, Dan Zeltzer, Ph.D., from Tel Aviv University in Israel, and colleagues conducted a retrospective cohort study to compare initial AI recommendations with final recommendations of physicians who had access to the AI recommendations and may or may not have reviewed them. Data were collected from a virtual primary and urgent care clinic. Data were included for 461 physician-managed visits for adults with respiratory, urinary, vaginal, eye, or dental symptoms from June 12 to July 14, 2024, with AI recommendations of sufficient confidence and complete medical records.
The researchers found that for 56.8 percent of the visits, initial AI and final physician recommendations were concordant. AI recommendations were more often rated as optimal compared with treating physician decisions (77.1 versus 67.1 percent). Quality scores were equal, better for AI, and better for treating physicians in 67.9, 20.8, and 11.3 percent of cases, respectively.
"AI can enhance clinical decision-making for common acute symptoms in a virtual urgent care setting," the authors write. "Thoughtful integration of AI into clinical practice, combining its strengths with those of physicians, could improve the quality of care."
The study was funded by K Health.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Risk for Mortality Higher Based on Wildfire PM2.5 Than Total PM2.5
TUESDAY, Aug. 26, 2025 -- On a global scale, relative risk for mortality associated with wildfire fine particulate matter (PM2.5) is greater than for total PM2.5, according to a...
Omega-3 PUFA Intake May Be Protective Against Myopia
MONDAY, Aug. 25, 2025 -- Omega-3 polyunsaturated fatty acid (ω-3 PUFA) intake may be protective against myopia in children, according to a study published online Aug. 19 in...
Molgramostim Beneficial in Autoimmune Pulmonary Alveolar Proteinosis
THURSDAY, Aug. 21, 2025 -- In adults with autoimmune pulmonary alveolar proteinosis (aPAP), once-daily inhaled molgramostim, a recombinant human granulocyte-macrophage...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.